Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model

HAE:TSX MONTREAL, Sept. 11 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, disclosed today the positive results of a second preclinical study con...

Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure

(TSX:HAE) MONTREAL, April 8 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX:HAE), a specialty bio-therapeutics company developing high-value human therapeutic proteins for commercialization, will hold its Annual General and Special Meeting of Shareholders on:...

Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals, Inc. and Second Quarter 2009 Financial Results

...SX MONTREAL, June 11 /PRNewswire-FirstCall/ - haemacure Corporation (TSX : HAE) released today the results... June 3, 2009, Angiotech Pharmaceuticals, Inc. and haemacure have entered into a strategic collaboration which ...Financing Also on June 3, 2009, Angiotech and haemacure entered into a bridge loan agreement in the minimu...

Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products

... HAE:TSX haemacure Completes US$2.5 Million Bridge Financing from Ang...ch MONTREAL, June 3 /PRNewswire-FirstCall/ - haemacure Corporation (TSX:HAE), a Montreal-based specialty bio-therapeutics company, announces that haemacure and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI...

Haemacure Update on Proposed Collaboration and Bridge Financing

...009 MONTREAL, May 22 /PRNewswire-FirstCall/ - haemacure Corporation (TSX:HAE), a Montreal-based specialty ...unced senior secured bridge loan from Angiotech to haemacure in the amount of US$2.5 million. haemacure and Angiotech expect that the closing of the bridg...

Haemacure Signs Term Sheet for Proposed Collaboration and Bridge Financing

...:TSX MONTREAL, May 4 /PRNewswire-FirstCall/ - haemacure Corporation (TSX:HAE), a Montreal-based specialty ...an from Angiotech in the amount of US$2.5 million. haemacure expects that the bridge loan will enable it to ope...the loan. The bridge loan will be convertible into haemacure securities in certain circumstances. "This is gr...

Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company

...X MONTREAL, March 12 /PRNewswire-FirstCall/ - haemacure Corporation (TSX : HAE) released today the results... Galli Chairman & CEO of Haemacure. About haemacure haemacure Corporation is a specialty biotherapeutics company...

Haemacure Restructures - Seeks Financing or Sale of the Company

...SX MONTREAL, Feb. 13 /PRNewswire-FirstCall/ - haemacure Corporation (TSX:HAE) announces that it has implem...nded to lead to a sale or merger of the Company. haemacure has been seeking financing since the third quarter...g. In light of the state of the financial markets, haemacure believes that without operational changes its cash...

Haemacure to Present at the 11th Annual BIO CEO & Investor Conference

...HAE MONTREAL, Feb. 3 /PRNewswire-FirstCall/ - haemacure Corporation (TSX: HAE) announced today that Joseph Galli, Chairman and Chief Executive Officer of haemacure will present at the BIO CEO & Investor Confere...ct candidate, Hemaseel(R)HMN (fibrin sealant). The haemacure presentation is scheduled to begin at 10 AM local ...

Haemacure Announces Fiscal 2008 Results

...SX MONTREAL, Jan. 21 /PRNewswire-FirstCall/ - haemacure Corporation (TSX:HAE), a Montreal-based specialty ...marked by significant additions to competencies as haemacure was successful in recruiting Mr. Reinaldo M. Diaz ...cluded Mr. Galli. Manufacturing Facility haemacure is processing plasma at its state-of-the-art manuf...

Haemacure in Medical Technology

Haemacure Announces Preliminary Findings of its Plasma Discard Analysis

...hese findings take on a strategic significance for haemacure as revenues eventually generated from the commerci...iotechnology companies." concluded Mr. Galli. haemacure plans on harvesting albumin from this discard and ...pha-iduronidase, used to treat Hurler's disease. haemacure has also identified three other enzymes, used to t...

Haemacure in Biological Technology

Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation

Angiotech to Provide $2.5 Million Bridge Facility to Haemacure VANCOUVER, June 3 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP), a specialty pharmaceutical and medical device company, announced today the completion of a collaboration transaction with Haem...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

...stribution, Development and Supply Agreements with haemacure Corporation. In June 2009, we announced that we ha...reements for fibrin and thrombin technologies with haemacure Corporation ("Haemacure"). The collaboration provi...f this collaboration, we have agreed to provide to haemacure a senior secured bridge financing facility. The se...